Published On:August 21 2014
Story Viewed 2417 Times
Claris Lifesciences gets Medicines and Healthcare products Regulatory Agency's nod for new plant.
Drug firm Claris Lifesciences has received approval by the UK health regulator, Medicines and Healthcare products Regulatory Agency (MHRA) for its newly commissioned plant in Ahmedabad.
'This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for plant 2,' Claris Lifesciences said in a filing on BSE.
This approval is for products presented in glass ampoules manufactured in line 1 of plant 2, it added.
'This will help in enhancing capacities to grow in regulated markets, especially the European Union. The company's speciality injectables business saw a growth of 30 per cent in the last quarter,' Claris Lifesciences said.
The company's plant 1 is already approved by MHRA-UK, it added
Ahmedabad based Claris Lifesciences is a sterile injectables pharmaceutical company with a market presence across 100 countries worldwide.